肾血流量与常染色体显性多囊肾病进展至肾衰竭的关系
在379例早期ADPKD患者中,基线肾血流量(RBF)最低三分位组肾衰竭发生率最高,为1.90/100人年,最高三分位组为0.34/100人年。完全校正后,最低RBF三分位组进展至肾衰竭的风险显著高于最高三分位组(HR 3.19,95%CI 1.05-9.67)。较高的RBF与较慢的eGFR下降和较低的年htTKV快速变化几率相关。
要点
- 低基线RBF独立关联早期ADPKD患者进展至肾衰竭风险增高。
- 最低RBF三分位组肾衰竭风险为最高三分位组的3.19倍(95%CI 1.05-9.67)。
- 较高RBF与较慢的eGFR下降和较低的年htTKV快速变化几率相关。
核心结论
- 在早期ADPKD患者中,较低的基线RBF独立与进展至肾衰竭风险增高相关。
研究设计与样本
- 纳入HALT PKD A研究中379例早期ADPKD患者,基线平均年龄36.6±8.5岁,eGFR 92.9±17.1 ml/min/1.73 m2,基线RBF采用相位对比磁共振成像测量。
- 采用Kaplan-Meier生存分析和多因素Cox比例风险模型评估基线RBF与肾衰竭风险的关联,中位随访13.1年(四分位距7.5-14.5),并链接USRDS数据库。
- 采用Fine和Gray方法将全因死亡作为竞争风险,采用线性和逻辑回归模型评估RBF与eGFR斜率及htTKV变化(∆htTKV)的关联。
主要发现
- 肾衰竭发生率在最低RBF三分位组最高,为1.90(95%CI 1.31-2.78)事件/100人年,最高三分位组为0.34(95%CI 0.14-0.83)事件/100人年。
- 完全校正模型中,最低RBF三分位组进展至肾衰竭风险高于最高三分位组,HR 3.19(95%CI 1.05-9.67)。
- 将死亡作为竞争风险后关联相似,每100 ml/min/1.73 m2较高RBF的HR为0.82(95%CI 0.67-1.00)。
- 较高RBF与较慢的eGFR下降和较低的年htTKV快速变化几率相关。
临床怎么用
- 在早期ADPKD患者中,基线RBF可能有助于识别肾衰竭进展高风险个体。
- RBF较低的ADPKD患者或需更密切的肾功能和影像学监测。
局限性
- RBF与肾衰竭风险的关联在校正模型中略有减弱。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A decrease in renal blood flow (RBF) precedes estimated glomerular filtration rate (eGFR) decline among patients with autosomal dominant polycystic kidney disease (ADPKD) and inversely associates with disease severity and progression. However, it is unknown whether RBF independently predicts progression to kidney failure in patients with ADPKD. METHODS: A total of 379 participants with early-stage ADPKD (mean age 36.6 ± 8.5 years; eGFR: 92.9 ± 17.1 ml/min/1.73 m2) who participated in the Halt Progression of Polycystic Kidney Disease Study A (HALT PKD A; NCT00283686) with baseline RBF (phase contrast magnetic resonance imaging) data were included in the primary analysis. Kaplan-Meier survival analysis and multivariate Cox proportional hazard models were used to determine the association of baseline RBF as a continuous and categorical variable with kidney failure risk (during the HALT study and subsequently linked to the US Renal Data System) over a median follow-up period of 13.1 years (interquartile range 7.5-14.5) (primary outcome). All-cause mortality was also considered as a competing risk (Fine and Gray method). The associations of RBF with eGFR slope and the change in height-adjusted total kidney volume (∆htTKV) were evaluated with linear and logistic regression models. RESULTS: The kidney failure incidence rate was the highest among those with the lowest RBF tertile {1.90 [95% confidence interval (CI) 1.31-2.78] versus 0.34 [95% CI 0.14-0.83] events/100 person-years in tertile 3}. In the fully adjusted model, the lowest RBF tertile was associated with a higher risk of progression to kidney failure [hazard ratio (HR) 3.19 (95% CI 1.05-9.67] versus the highest tertile]. The association of RBF with kidney failure risk was slightly attenuated in adjusted models. All associations remained similar when considering death as a competing risk [HR 0.82 (95% CI 0.67-1.00) per 100 ml/min/1.73 m2 higher RBF]. Higher RBF was associated with a slower eGFR decline and lower odds of rapid annual ∆htTKV. CONCLUSIONS: Lower baseline RBF independently associates with a greater risk of progression to kidney failure in early-stage patients with ADPKD.
引用
- Nowak KL, Copeland TP, Ku E, et al. Renal blood flow and progression to kidney failure in ADPKD. Nephrol Dial Transplant. 2026. PMID: 41811969. doi:10.1093/ndt/gfag059
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。